Immuneel Therapeutics Secures INR 100 Crore to Fuel Expansion
Immuneel Therapeutics, the biotech company founded by Kiran Mazumdar-Shaw, closed an investment round that fetched INR 100 crores ($15 million) to scale up its operations and research facilities.
Immuneel Therapeutics was born with the vision to affect paradigm-changing transformations in the cure of cancer.
While the names of investors in this round were not disclosed, prominent investors came out for the funding round, a fact that signals very strong market confidence in Immuneel’s mission and potential.
The strategic activities at the company will set the stage for substantial progress in treating the dreadful cancer menace and personalized medicine, which is already aided by the recent funding.